Dosing Protocol
Typical Dose 1 mg
Range 0.25 - 2.4 mg
Loading Phase 0.25 mg × 28 days
Maintenance 1 mg weekly
Pharmacokinetics
Half-Life 7.0 days
Onset 1.0 days
Peak 2.0 days
Duration 7.0 days
Bioavailability 89%
Primary Route Subcutaneous
Administration
Routes Subcutaneous, Oral
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 30-31G
Syringe Type Standard
Timing same day weekly
Special Instructions
Inject same day each week. Rotate injection sites. Oral form (Rybelsus) available - take on empty stomach with small sip of water.